Sulfasalazine induced lung toxicity masquerading as sarcoidosis - Case report and review of the literature

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 30, Issue 3, 2013, Pages 226-230

  Mohyuddin, G R ^a   Sultan, F ^a   Zhang, K ^a   Khaleeq, Ghulam ^a,b  

^a GEISINGER MEDICAL CENTER   (United States)

^b Departments of Pulmonary Disease Critical Care and Sleep Medicine   (United States)

Author keywords

Adenopaty; Sarcoidosis; Sulfasalazine

Indexed keywords

ENEMA; MESALAZINE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ARTICLE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG WITHDRAWAL; DYSPNEA; ENDOBRONCHIAL ULTRASONOGRAPHY; EOSINOPHIL; FEMALE; GRANULOMA; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN TISSUE; HYPOXEMIA; INFLAMMATORY BOWEL DISEASE; INTERSTITIAL PNEUMONIA; LOEFFLER PNEUMONIA; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG TOXICITY; LYMPHADENOPATHY; LYMPHOCYTE; MEDICAL HISTORY; MIDDLE AGED; MONOCYTE; NEUTROPHIL; OXYGEN SATURATION; PATIENT HISTORY OF LUNG TRANSPLANTATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SMOKING; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; ULCERATIVE COLITIS; COLITIS, ULCERATIVE;

ARTHRITIS, RHEUMATOID; COLITIS, ULCERATIVE; GRANULOMA; HUMANS; SARCOIDOSIS; SULFASALAZINE;

EID: 84921511111     PISSN: 11240490     EISSN: 2532179X     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Parry SD, Barbatzas C, Peel ET, Barton JR. Sulphasalazine and lung toxicity. Eur Respir J. 2002 Apr;19(4):756-64.
2. Dempsey OJ, Paterson EW, Kerr KM, Denison AR. Sarcoidosis. BMJ. 2009;339:b3206.
3. Hayashi T, Nakamura T, Kurachi K, Asai Y, Nakajima A, Suzuki S, et al. Ulcerative colitis accompanied with sarcoidosis and dermatomyositis: report of a case. Dis Colon Rectum. 2008 Apr;51(4):474-6.
4. Sostegni R, Daperno M, Pera A. Pulmonary manifestations of inflammatory bowel disease. Dig Liver Dis. 2007 Mar;39(3):239-41.
5. Schleiermacher D, Hoffmann JC. Pulmonary abnormalities in inflammatory bowel disease. J Crohns Colitis. 2007 Dec;1(2):61-9.
6. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-1993. A 44-year-old man with pulmonary disease and proctitis. N Engl J Med. 1993 Mar 25;328(12):869-76.
7. Salerno SM, Ormseth EJ, Roth BJ, Meyer CA, Christensen ED,Dillard TA. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener's granulomatosis. Chest. 1996 Aug;110(2):556-9.
8. Lorente JA P-RE, Badala G, Fogue L. Pulmonary disease induced by salazopyrine coexisting with pulmonary tuberculosis. Med Clin. 1989;93(476).
9. Bargon J, Rust M, Kardos P, Schneider M, Meier-Sydow J. [Salazo-sulfapyridine-induced eosinophilic pneumonia with pulmonary and cutaneous epithelioid cell granulomatosis in Sjogren syndrome]. Pneumologie. 1990 Apr;44(4):744-50.
10. Kolbe J, Caughey D, Rainer S. Sulphasalazine-induced sub-acute hyper-sensitivity pneumonitis. Respir Med. 1994 Feb;88(2):149-52.
11. Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol. 1987 Dec;14(6):1164-71.
12. Brimblecombe R. Mesalazine: a global safety evaluation. Scand J Gastroenterol Suppl. 1990;172:66.
13. Foster RA, Zander DS, Mergo PJ, Valentine JF. Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations. Inflamm Bowel Dis. 2003 Sep;9(5):308-15.